Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hematologic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obesity 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Multiple Myeloma 1Motor Activity 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Hairy Cell 1Leukemia 1Hodgkin Disease 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Colorectal Neoplasms 1Cardiotoxicity 1Carcinoma, Merkel Cell 1Breast Neoplasms 1

Interventions

Exercise 22Surveys and Questionnaires 3Resistance Training 3Diet 3Control Groups 3Nutrition Assessment 2Methods 2Interviews as Topic 2High-Intensity Interval Training 2Exercise Therapy 2Counseling 2pertuzumab 1pembrolizumab 1cytisine 1cemiplimab 1avelumab 1Weights and Measures 1Trastuzumab 1Therapeutics 1Telemedicine 1Standard of Care 1Spirometry 1Rehabilitation 1Psychiatric Rehabilitation 1Palliative Care 1Paclitaxel 1Nivolumab 1Neoadjuvant Therapy 1Ipilimumab 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Motor Activity × Exercise Test × Clear all
NCT02494869 2025-08-27

Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
75 enrolled

Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡